文献速递免疫规划传染病防控与疫情报告

巴西引入肺炎球菌结合疫苗前后住院儿童侵袭性肺炎球菌疾病分析

Invasive pneumococcal disease among hospitalized children in Brazil before and after the introduction of a pneumococcal conjugate vaccine.
PubMed 文献 · Vaccine · 2019-12-23

该研究基于巴西医院回顾性历史系列,纳入260例实验室确诊的住院侵袭性肺炎球菌疾病患儿,比较PCV10纳入免疫规划前后(2005-2009年与2011-2015年)疾病率、住院病死率及ICU入住需求。结果显示PCV10引入后住院率与病死率均显著下降,但PCV13额外血清型及非PCV13血清型所致感染比例上升。

要点

  • PCV10引入后住院率由每万例儿科住院20例降至5例(p<0.0001)。
  • 病死率由每万例儿科住院6.6例降至2.0例(p<0.0001)。
  • PCV13额外血清型占比由7%升至21%,非PCV13血清型由11%升至29%。

核心结论

  • 巴西引入PCV10后,侵袭性肺炎球菌疾病住院率、ICU入住率和病死率均显著下降,但非PCV10血清型感染率上升。

研究设计与样本

  • 医院回顾性历史系列,纳入260例实验室确诊的住院侵袭性肺炎球菌疾病患儿,比较疫苗接种前(2005-2009年)与接种后(2011-2015年)的疾病率与血清型。

主要发现

  • 共识别260例侵袭性肺炎球菌疾病且肺炎球菌分离阳性的患者,其中PCV10前时期198例。
  • 住院率由每万例儿科住院20例降至5例(p<0.0001),病死率由每万例儿科住院6.6例降至2.0例(p<0.0001)。
  • 肺炎是最常见临床诊断(58%),其中49.6%伴胸腔积液;其次为脑膜炎(22%)和菌血症(15.9%)。
  • 30%病例入住ICU,PCV10使用后百分比无变化。
  • PCV13额外血清型占比由引入前7%升至PCV10使用后21%,非PCV13血清型由11%升至29%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Most of the available data on invasive pneumococcal disease in Latin America are derived from laboratory-based surveillance systems. There is a lack of epidemiological data on the disease severity and mortality from hospitalized patients with pneumococcal infection. METHODS: In this hospital-based retrospective historical series of hospitalized children with laboratory-confirmed IPD, we evaluated changes in disease episodes, in-hospital fatality rates, and need for intensive care unit admission after the inclusion of PCV10 in the Brazilian vaccination schedule. Invasive pneumococcal strains isolated by culture were serotyped. Changes over time were assessed, and pre-vaccination (2005-2009) to post-vaccination (2011-2015) disease rates and serotypes were compared. RESULTS: 260 patients with IPD and positive pneumococcal isolates were identified (198 during the pre-PCV10 period). When comparing both periods, hospitalizations were reduced from 20 cases to 5 cases per 10,000 pediatric admissions (p < 0.0001). Likewise, fatalities reduced from 6.6 to 2.0 cases per 10,000 pediatric admissions (p < 0.0001). Pneumonia was the most frequent clinical diagnosis (58%) - of which 49.6% had pleural effusion - followed by meningitis (22%) and bacteremia (15.9%). Overall 30% of cases were sent to ICU, with no percentual changes after PCV10. Additional PCV13 serotypes increased from 7% before vaccine introduction to 21% after PCV10 use. Similarly, serotypes not included in PCV13 increased from 11% to 29%. CONCLUSIONS: There was a significant reduction in the hospitalizations rates, ICU admissions, and fatalities due to IPD after PCV10 introduction in Brazil. Cases due to PCV10 serotypes were reduced, while infections rates caused by non-PCV10 serotypes increased.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Berezin EN, Jarovsky D, Cardoso MRA, et al. Invasive pneumococcal disease among hospitalized children in Brazil before and after the introduction of a pneumococcal conjugate vaccine. Vaccine. 2019. PMID: 31874778. doi:10.1016/j.vaccine.2019.12.038

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。